Is CYP2C19 useful for Stress?

The short answer: No, CYP2C19 genotyping is not directly useful for assessing or managing 'stress' as a general condition. CYP2C19 is a drug-metabolizing enzyme primarily relevant for medications like clopidogrel, proton pump inhibitors, and certain antidepressants (e.g., escitalopram, sertraline). In theory, if stress manifests as an anxiety or depressive disorder requiring pharmacotherapy, knowing your CYP2C19 metabolizer status could guide dosing. However, current evidence is limited: most clinical guidelines do not recommend routine pharmacogenetic testing for first-line stress or anxiety treatment. Moreover, no robust studies link CYP2C19 variants directly to physiological stress markers (cortisol, heart rate variability). Therefore, for the average person seeking to reduce stress, lifestyle interventions (exercise, sleep, mindfulness) are far more evidence-based than genetic testing. The evidence level for this specific use is 'mixed' at best, with no direct clinical utility established.